FDA approves drug for PET scanning for prostate cancer patients
The U.S. Food and Drug Administration (FDA) approved the first drug to be used for positron emissions tomography (PET) imaging for prostate cancer on Dec. 1. Read More »
The U.S. Food and Drug Administration (FDA) approved the first drug to be used for positron emissions tomography (PET) imaging for prostate cancer on Dec. 1. Read More »
The U.S. Food and Drug Administration approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers’ diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool. Read More »
The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye). Read More »